
European regulators are investigating Google’s proposed $2.1 billion takeover of Fitbit, the San Francisco-based wearable technology maker, the Financial Times reported.
Consumer and privacy groups have argued that the deal should be blocked because Fitbit will give its new owner more data, making it impossible for other providers to compete against the popular search engine and advertising business, the news service reported.
The European Union (EU) sent in-depth questionnaires to Google’s and Fitbit’s rivals to determine whether the merger could potentially hurt competition – specifically, whether fitness tracking apps in Google’s Play Store will suffer and whether the deal would provide Google with expanded profiling information to give its online search and advertising businesses an advantage, the report noted.
In a separate move, nearly two dozen consumer groups, including the European Consumer Organization (the Belgium-based umbrella group that represents 45 consumer agencies from 32 countries), and the Consumer Federation of America, the Washington, D.C. consumer interest nonprofit, sent out a warning about the transaction on Thursday (July 2).
“Regulators must assume that Google will in practice utilize the entirety of Fitbit’s currently independent unique, highly sensitive data set in combination with its own, particularly as this could increase its profits, or they must impose strict and enforceable limitations on data use,” they said in a joint statement.
Full Content: PYMNTS
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas